Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bogliptin maleate in Chinese adults with type 2 diabetes mellitus (Phase I/II)
CTR20221768Phase 2Completed
- Sponsor
- Shandong Bio-G-D Pharmaceutical
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bogeliptin in type 2 diabetes mellitus (T2DM), sponsored by Shandong Bio-G-D Pharmaceutical. Started Jul 2022; status: completed.
02
Drugs
bogeliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20221768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221768.